Citigroup Inc. (C)

Citigroup's stock is trading at $124.21, sitting between its 20-day EMA at $123.37 and its 200-day average at $126.85, and it remains below both longer-term averages. The latest move came on October 30, 2026, when JP Morgan kept its Overweight rating, a reminder that Wall Street still leans positive even as the shares have lagged. The stock is priced at a steep discount on earnings: a trailing P/E of 12.11 against a sector median of 16.5.

Citigroup has beaten the EPS estimate in each of its last seven reported quarters. The October 13, 2026 report delivered adjusted EPS of $2.83 against an estimate of $2.62, a beat of 8.02%, yet the shares fell 5.60% in the first trading session after it. The July 14, 2026 report showed the same pattern, with a 15.87% beat followed by a 5.29% drop. Across the seven reports, the share price fell in the first session after two of them and rose after five, so a beat has not reliably lifted the stock on the day it is published. The April 14, 2026 report, a 17.69% beat, was followed by a 2.61% gain, and the October 14, 2025 beat of 17.10% was followed by a 3.89% rise. Investors have been judging the results against expectations that already priced in strong profits, rather than against the headline beat alone.

At $124.21 the stock trades on a trailing P/E of 12.11, which is 35.0% below the sector median of 16.5, and its price-to-sales ratio of 2.47 is 40.8% below the sector median of 3.8. Revenue grew 14.33% in the latest quarter year on year, ahead of the sector median of 11.7%. Return on equity of 9.35% sits below the sector median of 13.8%, and that gap in profitability relative to capital is the clearest reason the market may be reluctant to close the valuation gap. Analysts expect EPS to rise 51.5% this fiscal year to $11.40 and 14.5% next year to $13.06.

Insiders sold $23.3M of stock across 10 sales over the last 18 months and made no open-market purchases in that period. Such sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be. The absence of insider buying does not on its own point to trouble, but it does mean insiders have not been adding to their holdings at prices near the recent range.

Of 23 analysts with a current rating, 18 rate the stock buy or strong buy, 5 hold it, and none sell it. Three months ago 17 of 22 ratings were buys, so the buy count has edged up. JP Morgan kept its Overweight rating on October 30, 2026, and TD Cowen restarted coverage at Buy on October 8, 2026. UBS kept its Neutral rating on October 5, 2026, and Evercore ISI Group kept its In-Line rating on October 14, 2026, which are the main hold-leaning views on record.

The base case is that Citigroup trades in a range while it repairs its trend. The stock sits below both its 50-day SMA of $128.34 and its 200-day SMA of $126.85, and the 50-day remains above the 200-day by 1.18%, so a sustained move back above those averages would be the first sign that momentum is turning. The analysts' median 12-month target of $150.00 implies room to run, and their range runs from $127.00 to $170.00 across 23 analysts, with 18 rating the stock buy or strong buy. Upside would depend on earnings beats continuing and on the stock reacting more positively to them. Downside would come if the shares fall back through the 20-day EMA and the trend factor weakens further, or if a beat again leads to a sell-off. Simulations built from past volatility are not forecasts, and the typical daily move of 1.87% is a reminder that short-term swings can be large.

Nearest support is the 20-day EMA at $123.37, which the price is only just above. Below it, the 52-week low at $95.83 is the next major floor and marks the bottom of the stock's year-long range. Resistance starts with the 200-day SMA at $126.85, the level a rise would meet first. Above that, the 50-day SMA at $128.34 is the next barrier, and the 52-week high at $147.96 sits at the top of the range.